Home > Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance
 

Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance

Hantschel, Oliver

Published in:
Haematologica, 97, 2, 157-9
Year:
2012
ISSN:
1592-8721
Keywords:
Leukemia ; Myelogenous ; Chronic ; BCR-ABL Positive
Note:
Comment / Editorial
DOI:
10.3324/haematol.2012.061812
Other identifiers:
View record in Web of Science
Laboratories:
UPHAN

Record appears in:
Scientific production and competences > SV - School of Life Sciences > ISREC - Swiss Institute for Experimental Cancer Research > UPHAN - Prof. Hantschel Group
Publicly available
Work produced at EPFL
Published
Reviews



 Record created 2013-11-29, last modified 2018-03-17

Publisher's version:
Download fulltext
PDF
Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)